(Sharecast News) - Evotec tumbled on Wednesday after the German biotech firm warned on profits.
In a press release late on Tuesday, Evotec cut its FY2024 guidance for adjusted earnings before interest, tax, depreciation and amortisation to between €15m and €35m.

Revenues are expected to be between €790m and €820m,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE